Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?

Melanoma Res. 2006 Oct;16(5):377-8. doi: 10.1097/01.cmr.0000232298.37279.a1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / chemistry
  • Antigens, CD / chemistry
  • Antigens, CD / immunology*
  • Antigens, Differentiation / chemistry
  • Antigens, Differentiation / immunology*
  • Antigens, Neoplasm / metabolism
  • Autoimmune Diseases / therapy*
  • Autoimmunity
  • CTLA-4 Antigen
  • Cancer Vaccines
  • Humans
  • Immunotherapy / methods*
  • Melanoma / immunology*
  • Melanoma / therapy*
  • Organ Transplantation / methods
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / therapy

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation
  • Antigens, Neoplasm
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Cancer Vaccines